Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: Potential for drug target

Methionine aminopeptidases (MetAP) are proteases which remove the N-terminal methionine from newly synthesized proteins. Associations of MetAP2 with tumor progression of different cancers have been repeatedly reported. We aim to determine if MetAP2 is expressed in cholangiocarcinomas (CCA) and investigate to see if it would be a useful therapeutic target. We evaluated MetAP2 expression by immunohistochemistry in 82 patients of intrahepatic CCA. MetAP2 was expressed in bile ducts to various degrees. It was occasionally expressed with weak staining in normal bile duct epithelium but was strikingly over-expressed in dysplastic bile duct epithelia, primary and metastatic CCA tissues (p < 0.001). The increased expression of MetAP2 in proliferating bile duct was evident. All metastatic tumors had stronger expression of MetAP2 than the corresponding primary tumors. Fumagillin, a MetAP2 specific inhibitor, significantly inhibited cell proliferation in dose dependent manner and the degree of growth inhibition was dependent on the amount of cellular enzyme. The present study highlights the involvement of MetAP2 in an early event of carcinogenesis of CCA. The findings represent the first description of increased MetAP2 expression in CCA. The inhibition of enzyme activity using MetAP2 inhibitors may be a potential strategy for long-term control of tumor development and progression in CCA patients.

[1]  Nam-Soon Kim,et al.  Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags. , 2006, Biochemical and biophysical research communications.

[2]  J. Maris,et al.  Prospects for therapeutic inhibition of neuroblastoma angiogenesis. , 2005, Cancer letters.

[3]  C. D. Thompson,et al.  Methionine aminopeptidases type I and type II are essential to control cell proliferation , 2005, Journal of cellular biochemistry.

[4]  M. Miwa,et al.  Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). , 2005, World journal of gastroenterology.

[5]  Yusuke Nakamura,et al.  Genome‐wide analysis of gene expression in human intrahepatic cholangiocarcinoma , 2005, Hepatology.

[6]  P. Jennings,et al.  Temperature, media, and point of induction affect the N-terminal processing of interleukin-1beta. , 2005, Protein expression and purification.

[7]  Yie-Hwa Chang,et al.  Yeast Glutamine-fructose-6-phosphate Aminotransferase (Gfa1) Requires Methionine Aminopeptidase Activity for Proper Function* , 2005, Journal of Biological Chemistry.

[8]  E. Chun,et al.  Novel inhibitors targeted to methionine aminopeptidase 2 (MetAP2) strongly inhibit the growth of cancers in xenografted nude model , 2005, International journal of cancer.

[9]  I. Sheen,et al.  Fumagillin treatment of hepatocellular carcinoma in rats: an in vivo study of antiangiogenesis. , 2005, World journal of gastroenterology.

[10]  Alphonse E. Sirica,et al.  Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy , 2005, Hepatology.

[11]  M. Olnes,et al.  A Review and Update on Cholangiocarcinoma , 2004, Oncology.

[12]  Erik Schrumpf,et al.  Diagnosis and treatment of cholangiocarcinoma , 2004, Current gastroenterology reports.

[13]  Motoko Sasaki,et al.  Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. , 2003, Journal of hepato-biliary-pancreatic surgery.

[14]  G. Gores.  Cholangiocarcinoma: Current concepts and insights , 2003, Hepatology.

[15]  Arnab Ghosh,et al.  A glycosylation site, 60SGTS63, of p67 is required for its ability to regulate the phosphorylation and activity of eukaryotic initiation factor 2alpha. , 2003, Biochemistry.

[16]  H. Thomas,et al.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours. , 2002, Journal of hepatology.

[17]  K. Endo,et al.  ERBB‐2 overexpression and cyclooxygenase‐2 up‐regulation in human cholangiocarcinoma and risk conditions , 2002, Hepatology.

[18]  M. Fukayama,et al.  High Expression of Methionine Aminopeptidase Type 2 in Germinal Center B Cells and Their Neoplastic Counterparts , 2002, Laboratory Investigation.

[19]  L. Strizzi,et al.  Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity. , 2001, The American journal of pathology.

[20]  T. Patel.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.

[21]  J. Maris,et al.  The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  W. Figg,et al.  TNP-470: an angiogenesis inhibitor in clinical development for cancer , 2000, Expert opinion on investigational drugs.

[23]  Sun-Whe Kim,et al.  Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma , 2000, Hepatology.

[24]  K. Biemann,et al.  Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. , 1999, Chemistry & biology.

[25]  C. Shapiro,et al.  Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Eric C. Griffith,et al.  Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Widom,et al.  Structure of human methionine aminopeptidase-2 complexed with fumagillin. , 1998, Science.

[28]  J. V. Von Roenn,et al.  Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[30]  C. Verschraegen,et al.  A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  W. Bornmann,et al.  The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  K. Biemann,et al.  Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. , 1997, Chemistry & biology.

[33]  V. Castronovo,et al.  TNP-470 (AGM-1470): mechanisms of action and early clinical development. , 1996, European journal of cancer.

[34]  X Li,et al.  Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R A Bradshaw,et al.  Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Fan.  Angiosuppressive therapy for cancer. , 1994, Trends in pharmacological sciences.

[37]  D. Ingber,et al.  Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. , 1991, Biochemical and biophysical research communications.

[38]  D. Scudiero,et al.  New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.

[39]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[40]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[41]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[42]  T. Hunter,et al.  Role of Methionine in the Initiation of Haemoglobin Synthesis , 1970, Nature.